Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06730633 · ClinicalTrials.gov registry record · NA
Collaborate and Leverage Evidence in African American Rural Network
A NA study of Cardiovascular Diseases, sponsored by University of North Carolina, Chapel Hill.
- Active
- Registry status
- NA
- Development phase
- 173
- Enrollment target
- 9
- Study locations
NCT06730633: Active NA study of Cardiovascular Diseases, sponsored by University of North Carolina, Chapel Hill.
NCT06730633 is a NA study of Cardiovascular Diseases that is active but no longer recruiting, run by University of North Carolina, Chapel Hill. The registered enrollment target is 173 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 9 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06730633, a NA study of Cardiovascular Diseases, is active but no longer recruiting, sponsored by University of North Carolina, Chapel Hill.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 173 participants
- Enrollment target
- 9
- Study locations
Study Summary
The goal of this non-randomized, propensity-matched-controlled study is to assess the effectiveness of the Heart Matters evidence-based program -- previously evaluated for feasibility and efficacy in NCT02707432 -- in improving cardiovascular health outcomes (change in systolic and diastolic blood pressure, primary outcomes) when implemented by community-based facilitators.
Primary Outcome
Blood pressure is measured as the average of three readings, taken in a seated position using an Omron BP6100 digital blood pressure monitor. Reporting will compare participants in the present study with propensity-score-matched controls.
Conditions Studied
Interventions
- BEHAVIORAL Heart Matters
Study Locations (9)
North Carolina
- A Better Chance, A Better Community - Enfield
- The Mercer Foundation, Inc. - Nashville
- Marks Chapel Baptist Church - Rocky Mount
- Thorne's Chapel Missionary Baptist Church - Rocky Mount
- Truth Tabernacle Ministries - Rocky Mount
- Girls Making the Grade - Rocky Mount
- Carolina Hierarchy of Needs - Spring Hope
- St. James United Holy Church - Stantonsburg
- Warren County Health Department - Warrenton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2025-02-22 |
| Est. Completion | 2026-05 |
| Phase | NA |
What the registry record for NCT06730633 still lists
NCT06730633 is an interventional study that assigns participants to a tested intervention. The registered 173 participants enrollment target is mid-sized for trials with a published cap, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Heart Matters is the first listed.
NCT06730633 lists 9 locations in 1 state (North Carolina).
Frequently Asked Questions
What is clinical trial NCT06730633 about?
NCT06730633 is a clinical study titled "Collaborate and Leverage Evidence in African American Rural Network". The goal of this non-randomized, propensity-matched-controlled study is to assess the effectiveness of the Heart Matters evidence-based program -- previously evaluated for feasibility and efficacy in NCT02707432 -- in improving cardiovascular health outcomes (change in systolic and diastolic blood p...
What is the current status of trial NCT06730633?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 173 participants. The study started on 2025-02-22. Estimated completion is 2026-05.
What conditions does trial NCT06730633 study?
This clinical trial studies the following conditions: Cardiovascular Diseases.
What interventions are being tested in trial NCT06730633?
The interventions under investigation include: Heart Matters (BEHAVIORAL).
Who is sponsoring clinical trial NCT06730633?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06730633 being conducted?
This trial has 9 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06730633's enrollment target sits among peer trials
173 162nd of 300 higher than 139 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05568719 · 173 participants · Phase 3
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- NCT07070115 · 173 participants · NA
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
- NCT07150832 · 173 participants · NA
Efficacy of the I-CARE Digital Health Intervention
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI